Marek Ciszewski | SVP, IR |
Denny Lanfear | CEO |
Theresa Lavallee | Chief Development Officer |
Rosh Dias | Chief Medical Officer |
Paul Reider | Chief Commercial Officer |
McDavid Stilwell | CFO |
Salim Syed | Mizuho |
Douglas Tsao | HC Wainwright |
Chris Schott | JPMorgan |
Jason Gerberry | Bank of America |
Ash Verma | UBS |
Thank you for standing by, and welcome to Coherus Biosciences Fourth Quarter and Fiscal Year 2022 Earnings Conference Call. [Operator Instructions]
I would now like to hand the call over to SVP, Investor Relations, Marek Ciszewski. Please go ahead.
Thank you, Latif, and good afternoon, everyone, and thank you for joining us.